Tumor therapy with biologically active anti-tumor antibodies
US5091178A · kind A · utility
45Cited by
11References
3Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 30, 1990 |
| Grant date | Feb 25, 1992 |
| Priority date | — |
| Expiry date | Jan 30, 2010 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10S530/861
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A method for identifying and using antibodies which are directed against tumor-associated glycolipid antigens and which are capable of activating serum complement or antibody dependent cellular cytotoxicity. These antibodies find use in the therapy of tumors. Administration of the antibodies results in lysis of the tumor cells in vivo.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.